(Q37424837)

English

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

scientific article published on 07 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

9

object named as

Ellen Vitetta

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

8

object named as

Victor Ghetie

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

John Schindler

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Srikanth Gajavelli

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Yumin Shen

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Samir Parekh

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ira Braunchweig

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Stefan Barta

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Amit Verma

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

7 July 2011

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

154

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

471-476

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

23 August 2017

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

6 September 2017

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

14 September 2017

A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

14 September 2017

The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

28 September 2017

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

2 September 2018

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877839

2 September 2018

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/21732928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21732928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21732928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2011.08762.X

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37424837&oldid=2142166851"